Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate

The number of people infected with severe acute respiratory syndrome coronavirus 2 is increasing globally, and some patients have a fatal clinical course. In light of this situation, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020. While...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaka, Sho, Shono, Yuji, Tokuda, Kentaro, Nakashima, Kosuke, Yamamoto, Yuzo, Maki, Jun, Nagasaki, Yoji, Shimono, Nobuyuki, Akahoshi, Tomohiko, Taguchi, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409929/
https://www.ncbi.nlm.nih.gov/pubmed/32893123
http://dx.doi.org/10.1016/j.jiac.2020.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409929/
https://www.ncbi.nlm.nih.gov/pubmed/32893123
http://dx.doi.org/10.1016/j.jiac.2020.08.001

Ejemplares similares